News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Opexa Therapeutics (OPXA) Announces News Release And Conference Call To Discuss First Quarter 2014 Financial Results


5/12/2014 7:14:14 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Opexa Therapeutics, Inc. (NASDAQ: OPXA), a biotechnology company developing Tcelna®, a novel T-cell immunotherapy for the treatment of multiple sclerosis (MS), today announced that the Company will report financial results for the three months ended March 31, 2014 after the close of trading on Wednesday, May 14th. The company will also conduct a conference call and webcast to discuss financial results and provide a corporate update at 5:00 P.M. EDT on Wednesday, May 14th.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES